SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001818382-22-000096
Filing Date
2022-06-13
Accepted
2022-06-13 16:23:26
Documents
1
Period of Report
2022-06-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_165515179132864.html 4  
1 FORM 4 wf-form4_165515179132864.xml 4 3907
  Complete submission text file 0001818382-22-000096.txt   5413
Mailing Address C/O DERMIRA, INC. 275 MIDDLEFIELD ROAD, SUITE 150 MENLO PARK CA 94025
Business Address
Sebelius Kathleen (Reporting) CIK: 0001654316 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39532 | Film No.: 221011903

Mailing Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713
Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 919-313-9633
Humacyte, Inc. (Issuer) CIK: 0001818382 (see all company filings)

IRS No.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)